Page last updated: 2024-09-02
thromboxanes and ci 959
thromboxanes has been researched along with ci 959 in 1 studies
Compound Research Comparison
| Studies (thromboxanes) | Trials (thromboxanes) | Recent Studies (post-2010) (thromboxanes) | Studies (ci 959) | Trials (ci 959) | Recent Studies (post-2010) (ci 959) |
|---|---|---|---|---|---|
| 3,202 | 149 | 199 | 20 | 2 | 5 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Adolphson, RL; Conroy, MC; Schellenberg, RR; Thueson, DO | 1 |
Other Studies
1 other study(ies) available for thromboxanes and ci 959
| Article | Year |
|---|---|
CI-959, a new, potential antiallergic drug, inhibits mediator release from lung and contractions of human airways in vitro.
Topics: Animals; Bronchoconstriction; Dose-Response Relationship, Drug; Guinea Pigs; Histamine Antagonists; Histamine Release; Humans; Immunoglobulin E; Leukotrienes; Lung; Tetrazoles; Thiophenes; Thromboxanes | 1990 |